Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vor Biopharma Inc.

10.06
+0.22002.24%
Post-market: 9.67-0.3900-3.88%19:49 EST
Volume:1.33M
Turnover:13.36M
Market Cap:68.95M
PE:-0.03
High:10.50
Open:10.00
Low:9.72
Close:9.84
52wk High:65.80
52wk Low:2.62
Shares:6.85M
Float Shares:3.18M
Volume Ratio:0.63
T/O Rate:41.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-342.6591
EPS(LYR):-34.0333
ROE:-125.43%
ROA:-121.29%
PB:-0.05
PE(LYR):-0.30

Loading ...

Vor Biopharma Announces $93.7 Million Public Offering

TIPRANKS
·
Yesterday

Dow Gains More Than 300 Points; Energy Vault Holdings Shares Jump

Benzinga
·
Yesterday

Vor Biopharma Shares Fall 46.9% After Steeply Discounted $100 Mln Stock Offering

THOMSON REUTERS
·
Nov 11

BUZZ-U.S. STOCKS ON THE MOVE-Nebius, Estee Lauder, Soleno

Reuters
·
Nov 11

Top Premarket Decliners

MT Newswires Live
·
Nov 11

Vor Biopharma Shares Down 27.9% Premarket After Launching $100 Mln Stock Offering

THOMSON REUTERS
·
Nov 11

BRIEF-Vor Bio Prices Public Offering Of 10 Million Shares At $10 Each

Reuters
·
Nov 11

Vor Biopharma Inc - Prices Public Offering of 10 Mln Shares at $10 Each

THOMSON REUTERS
·
Nov 11

Vor Bio Stock Slides on Public Offering

Dow Jones
·
Nov 11

Vor Biopharma Shares Extend After-Hours Losses; Last Down 27.1%

THOMSON REUTERS
·
Nov 11

BUZZ-Vor Biopharma plunges after $100 mln stock offering launch

Reuters
·
Nov 11

Vor Bio announces $100M common stock offering

TIPRANKS
·
Nov 11

Vor Bio Announces Proposed Public Offering of $100 Million of Common Stock

THOMSON REUTERS
·
Nov 11

Stifel Nicolaus Sticks to Its Buy Rating for Vor Biopharma (VOR)

TIPRANKS
·
Nov 10

Vor Bio achieves primary endpoint in Stage A of Phase 3 study of telitacicept

TIPRANKS
·
Nov 10

BRIEF-Vor Biopharma Says Primary Endpoint Achieved In Phase 3 Clinical Study Evaluating Telitacicept

Reuters
·
Nov 09

Vor Biopharma Inc - Primary Endpoint Achieved in Stage a of a Phase 3 Clinical Study Evaluating Telitacicept in Adults With Iga Nephropathy

THOMSON REUTERS
·
Nov 09

Vor Bio to Participate in 8th Annual Evercore Healthcare Conference

Reuters
·
Nov 07

Vor Bio Appoints Jeremy Sokolove as Chief Medical Officer

Reuters
·
Nov 03

Vor Biopharma Inc expected to post a loss of $3.34 a share - Earnings Preview

Reuters
·
Nov 03